Synthesis and biological evaluation of N-acetyl-β-aryl-1,2-didehydroethylamines as new HIV-1 RT inhibitors in vitro

Add time:08/25/2019    Source:sciencedirect.com

A variety of N-acetyl-β-aryl-1,2-didehydroethylamines were synthesized by direct reduction–acetylation of β-aryl-nitroolefins and assayed as HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the first time. Compound 7a exhibited a TI value of >13.2 with CC50 value of >0.787 mM in C8166 cells. This structure–activity relationship (SAR) study provided a new lead for design and discovery of more potent and selective analogues act as NNRTIs.

We also recommend Trading Suppliers and Manufacturers of 1-(2,4,5-TRIMETHYLPHENYL)-2-THIOUREA (cas 117174-87-5). Pls Click Website Link as below: cas 117174-87-5 suppliers

Prev:Cost-effective and facile fluorescent probes for label-free recognition of chlorpromazine hydrochloride and logic gate operation
Next:Pyrrolo[1,2-b]pyridazines, pyrrolo[2,1-f]triazin-4(3H)-ones, and related compounds as novel corticotropin-releasing factor 1 (CRF1) receptor antagonists)